Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
Jazz Pharmaceuticals plc (NASDAQ: JAZZ is among the 11 Best Pot Stocks to Buy According to Hedge Funds Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate On February 25, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) reported Q4 revenue of $1.2 billion, exceeding consensus estimates of $1.17 billion and marking 10% year-over-year growth. According to Renee Gala, president and chief executive officer of Jazz Pharmaceuticals, 2025 was an exceptional year for the company. Management highlighted 2025 as its 21st consecutive year of top-line growth, underscoring operational execution and portfolio durability. It boasted a revenue of $1.2 billion for the fourth quarter of 2025, reflecting 10% year-over-year growth and the company's highest revenue quarter to date. Jazz Pharmaceuticals plc (NASDAQ:JAZZ) cited momentum heading into 2026, including the potential launch of zanidatamab in gastroesophageal adenocarcinoma, ongoing commercialization of Modeyso and
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Day One Biopharmaceuticals gains amid takeover speculation [Seeking Alpha]Seeking Alpha
- Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now? [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals' Record Revenue And Cancer Data Raise Durability Question [Yahoo! Finance]Yahoo! Finance
- Why Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Sales But Full-Year Loss [Yahoo! Finance]Yahoo! Finance
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 3/5/26 - Form 144
- 3/5/26 - Form 144
- 3/4/26 - Form 4
- JAZZ's page on the SEC website